- Larry Ellison plans to sell up to 50 million Oracle shares — roughly $7.5 billion at Friday’s $150 close — through an orderly trading plan running to the end of October 2026. The plan was established in late June, according to Oracle’s latest quarterly filing. Oracle declined to comment.
- The disclosure followed Thursday’s results, which showed higher data centre revenue but drew a dip in the share price as investors flagged continued margin compression from the company’s all-in AI bet. The sale is a fraction of Ellison’s holding: he remains the largest individual shareholder with a 40% stake.
- The scale of Oracle’s AI commitment is extraordinary relative to its balance sheet. The company agreed in September to supply $300 billion in capacity to OpenAI, a contract that briefly made Ellison the world’s richest person, and has raised substantial debt and issued new shares to fund it. Permitting and regulatory hurdles have already slowed the build-out.
- Cost discipline is running alongside the spending. Oracle disclosed a further $700 million allocated for severance in the coming year, after $2.1 billion last fiscal year when it cut tens of thousands of jobs. Ellison had also pledged 346 million Oracle shares as loan collateral as of September 2025.
What Happened?
Regulatory filings revealed Friday that Oracle’s 82-year-old co-founder and chair will offload as many as 50 million shares by the end of October under a pre-arranged trading plan. Ellison has been absent from recent earnings calls after decades as the public face of the company, though people close to him describe him as still highly active in day-to-day decisions. He has been central to Oracle’s data centre pivot, appearing at the White House in early 2025 alongside Sam Altman and Masayoshi Son to unveil OpenAI’s $500 billion Stargate plan, which has since fragmented into a series of bilateral deals.
Why It Matters?
A pre-planned sale set up in June is not a market call, and reading it as a signal on Oracle’s prospects would be a stretch. The more useful context is what the proceeds are likely for. Ellison is financing a $40 billion equity backstop for his son David’s hostile bid for Warner Bros Discovery through Paramount Skydance, alongside the Ellison Institute of Technology in Oxford and the Ellison Medical Institute in Los Angeles. With 346 million shares already pledged as loan collateral, liquidity rather than conviction is the plausible driver. For Oracle shareholders, the sharper issue is the financing structure underneath the OpenAI contract: a company funding a $300 billion capacity commitment with debt and equity issuance, while cutting staff and compressing margins, is running a balance sheet bet on a single counterparty.
What’s Next?
Watch whether the full 50 million shares are sold by the October deadline and whether a further plan follows. On the operating side, the permitting and regulatory obstacles slowing the OpenAI build-out are the binding constraint on revenue recognition, so capacity delivery milestones matter more than bookings. The Warner Bros Discovery situation is a live overhang given Ellison’s personal backstop — the Paramount Skydance merger is frozen until as late as next June while roughly a dozen states pursue antitrust challenges. Margin trajectory in the next quarter will show whether data centre revenue growth can outrun the cost of building it.
Source: Financial Times
